oxandrolone has been researched along with Burns in 43 studies
Oxandrolone: A synthetic hormone with anabolic and androgenic properties.
Burns: Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied the effect of an anabolic steroid, oxandrolone, combined with a high-protein diet (2 g/kg/day) on the rate of weight gain and restoration of muscle function in the recovery phase after deep burns of 30 of 50% of total body surface (n = 7)." | 9.08 | Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns. ( Demling, RH; DeSanti, L, 1997) |
| " Mortality, infection, and hepatic function: Oxandrolone therapy did not affect mortality (relative risk (RR)=0." | 8.93 | The efficacy and safety of oxandrolone treatment for patients with severe burns: A systematic review and meta-analysis. ( Guo, Q; Guo, Y; Li, H; Roy, M; Yang, Z, 2016) |
| "At present, beta-adrenergic blockade with propranolol represents probably the most efficacious anticatabolic therapy in the treatment of burns." | 8.87 | Burns: where are we standing with propranolol, oxandrolone, recombinant human growth hormone, and the new incretin analogs? ( Gauglitz, GG; Herndon, DN; Jeschke, MG; Williams, FN, 2011) |
| "Severe burns are associated with a significant loss of muscle and strength." | 6.73 | The effects of oxandrolone and exercise on muscle mass and function in children with severe burns. ( Herndon, DN; Przkora, R; Suman, OE, 2007) |
| "Oxandrolone was discontinued after at least 80% of the involuntary weight loss occurring in the acute burn period, was restored." | 6.71 | Oxandrolone induced lean mass gain during recovery from severe burns is maintained after discontinuation of the anabolic steroid. ( Demling, RH; DeSanti, L, 2003) |
| "Patients 0 to 18 years old with burns covering >30% of the total body surface area were randomized to receive placebo (n = 152) or oxandrolone, 0." | 5.16 | Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy. ( Finnerty, CC; Herndon, DN; Jennings, K; Klein, GL; Lee, JO; Meyer, WJ; Mlcak, RP; Porro, LJ; Rodriguez, NA; Suman, OE, 2012) |
| "Thirty-five children with > or =40% total body surface area burns were randomized to receive either placebo or oxandrolone (0." | 5.11 | The long-term effect of oxandrolone on hepatic acute phase proteins in severely burned children. ( Chinkes, DL; Herndon, DN; Murphy, KD; Thomas, S; Wolf, SE, 2004) |
| "Children with burns greater than 40% total body surface area were enrolled into a randomized controlled trial to receive oxandrolone as a long-term anabolic agent." | 5.11 | Effects of long-term oxandrolone administration in severely burned children. ( Chinkes, DL; Herndon, DN; Klein, GL; Mlcak, RP; Murphy, KD; Thomas, S, 2004) |
| "The authors previously showed that oxandrolone increased net muscle protein synthesis in emaciated burned patients receiving delayed treatment for severe burns." | 5.10 | Improved net protein balance, lean mass, and gene expression changes with oxandrolone treatment in the severely burned. ( Chinkes, DL; Dasu, MR; Ferrando, AA; Herndon, DN; Thomas, SJ; Wolf, SE; Wolfe, RR, 2003) |
| "We studied the effect of an anabolic steroid, oxandrolone, combined with a high-protein diet (2 g/kg/day) on the rate of weight gain and restoration of muscle function in the recovery phase after deep burns of 30 of 50% of total body surface (n = 7)." | 5.08 | Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns. ( Demling, RH; DeSanti, L, 1997) |
| " Mortality, infection, and hepatic function: Oxandrolone therapy did not affect mortality (relative risk (RR)=0." | 4.93 | The efficacy and safety of oxandrolone treatment for patients with severe burns: A systematic review and meta-analysis. ( Guo, Q; Guo, Y; Li, H; Roy, M; Yang, Z, 2016) |
| "Data support the efficacy of testosterone, oxandrolone, human recombinant growth hormone, insulin, metformin, and propranolol in improving skeletal muscle protein net balance in patients with severe burns." | 4.91 | Effects of pharmacological interventions on muscle protein synthesis and breakdown in recovery from burns. ( Børsheim, E; Diaz, EC; Herndon, DN; Porter, C; Sidossis, LS; Suman, OE, 2015) |
| " oxandrolone or placebo, in adults or children with burns." | 4.90 | Recombinant human growth hormone for treating burns and donor sites. ( Breederveld, RS; Tuinebreijer, WE, 2014) |
| "This study is a systematic literature review and meta-analysis concerning the use of a testosterone synthetic analog, oxandrolone, and its use in severe adult burns." | 4.90 | Oxandrolone use in adult burn patients. Systematic review and meta-analysis. ( Ferreira, LM; Gragnani, A; Okamoto, RH; Piccolo, MS; Real, DS; Reis, RP, 2014) |
| " oxandrolone or placebo, in adults or children with burns." | 4.88 | Recombinant human growth hormone for treating burns and donor sites. ( Breederveld, RS; Tuinebreijer, WE, 2012) |
| "At present, beta-adrenergic blockade with propranolol represents probably the most efficacious anticatabolic therapy in the treatment of burns." | 4.87 | Burns: where are we standing with propranolol, oxandrolone, recombinant human growth hormone, and the new incretin analogs? ( Gauglitz, GG; Herndon, DN; Jeschke, MG; Williams, FN, 2011) |
| " Vitamin D25 and D1,25 levels were lower in subjects with larger burns or inhalation injury, as well as those treated with thyroxine or oxandrolone." | 3.72 | Hypovitaminosis D in acutely injured pediatric burn patients. ( Gottschlich, MM; Khoury, J; Mayes, T; Warden, GD, 2004) |
| " The long-term administration of oxandrolone for 16 ± 1 months postburn (range, 12." | 2.82 | FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL. ( Andersen, C; Clayton, RP; Crites, NN; Finnerty, CC; Hays, JP; Herndon, DN; Jennings, K; Klein, GL; Lee, JO; Meyer, W; Mlcak, RP; Reeves, PT; Suman, OE; Tanksley, JD, 2016) |
| "Severe burns are associated with a significant loss of muscle and strength." | 2.73 | The effects of oxandrolone and exercise on muscle mass and function in children with severe burns. ( Herndon, DN; Przkora, R; Suman, OE, 2007) |
| "Oxandrolone was discontinued after at least 80% of the involuntary weight loss occurring in the acute burn period, was restored." | 2.71 | Oxandrolone induced lean mass gain during recovery from severe burns is maintained after discontinuation of the anabolic steroid. ( Demling, RH; DeSanti, L, 2003) |
| "The metabolic rate in untreated burns was 155 + 25% of predicted normal, compared to 178 +/- 28% for HGH and 156 +/- 20% for oxandrolone treated patients." | 2.69 | Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury. ( Demling, RH, 1999) |
| " Multicenter, prospective, randomized studies are needed to better define the optimal oxandrolone dosage and to confirm the efficacy and safety of this drug in adult patients with severe thermal injury." | 2.45 | Oxandrolone treatment in adults with severe thermal injury. ( Btaiche, IF; Miller, JT, 2009) |
| "Six hypertrophic scars were encountered on the control side and only one scar was encountered on the study side." | 1.51 | Topical Oxandrolone Reduces Ear Hypertrophic Scar Formation in Rabbits. ( Bodog, F; Fodor, L; Sobec, RL, 2019) |
| "In oxandrolone-treated mice (1mg/kg/day for up to 21 days) there was a significant amelioration of burn-induced accumulation of myeloperoxidase levels in heart and lung (but not the liver and kidney) and significantly lower degree of malon dialdehyde accumulation in the liver (but not the heart, lung and kidney)." | 1.51 | Oxandrolone protects against the development of multiorgan failure, modulates the systemic inflammatory response and promotes wound healing during burn injury. ( Ahmad, A; Herndon, DN; Szabo, C, 2019) |
| "Oxandrolone has proven benefits in thermal burn injury and has become a standard of care." | 1.51 | Risk Factors Associated with the Development of Transaminitis in Oxandrolone-Treated Adult Burn Patients. ( Foster, CJ; Gayed, RM; Hill, DM; Jones, KM; Kiracofe, B; Murphy, CV; Oltrogge Pape, K; Porter, K; Reger, M; Zavala, S, 2019) |
| "Oxandrolone is an anabolic steroid that has been used in cachectic hepatitis and AIDS patients." | 1.31 | Anabolic effects of oxandrolone after severe burn. ( Beauford, RB; Chinkes, DL; Ferrando, AA; Hart, DW; Herndon, DN; Ramzy, PI; Wolf, SE; Wolfe, RR, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.65) | 18.2507 |
| 2000's | 16 (37.21) | 29.6817 |
| 2010's | 20 (46.51) | 24.3611 |
| 2020's | 5 (11.63) | 2.80 |
| Authors | Studies |
|---|---|
| Zeitouni, F | 1 |
| Zhu, C | 1 |
| Pang, A | 1 |
| O'Banion, S | 1 |
| Bharadia, D | 1 |
| Griswold, J | 2 |
| Shahrokhi, S | 2 |
| Jeschke, MG | 8 |
| Ring, J | 1 |
| Heinelt, M | 1 |
| Sharma, S | 1 |
| Letourneau, S | 1 |
| Gus, EI | 1 |
| Knuth, CM | 1 |
| Auger, C | 1 |
| Chao, T | 1 |
| Porter, C | 2 |
| Herndon, DN | 18 |
| Siopi, A | 1 |
| Ideker, H | 1 |
| Mlcak, RP | 6 |
| Sidossis, LS | 2 |
| Suman, OE | 10 |
| Herndon, D | 1 |
| Capek, KD | 2 |
| Ross, E | 1 |
| Jay, JW | 1 |
| Prasai, A | 1 |
| Ayadi, AE | 1 |
| Foncerrada-Ortega, G | 1 |
| Blears, E | 1 |
| Sommerhalder, C | 1 |
| McMullen, K | 1 |
| Amtmann, D | 1 |
| Cox, R | 1 |
| Hundeshagen, G | 1 |
| Jennings, K | 3 |
| Sousse, LE | 2 |
| Meyer, WJ | 4 |
| Finnerty, CC | 7 |
| Dobbe, L | 1 |
| Clapp, C | 1 |
| Larumbe-Zabala, E | 1 |
| Kiracofe, B | 2 |
| Coffey, R | 1 |
| Jones, LM | 1 |
| Bailey, JK | 1 |
| Thomas, S | 3 |
| Porter, K | 2 |
| Murphy, CV | 2 |
| Sobec, RL | 1 |
| Fodor, L | 1 |
| Bodog, F | 1 |
| Ahmad, A | 1 |
| Szabo, C | 1 |
| Thorpe, CR | 1 |
| Ucer Ozgurel, S | 1 |
| Simko, LC | 1 |
| Goldstein, R | 1 |
| Grant, GG | 1 |
| Pagani, C | 1 |
| Hwang, C | 1 |
| Vasquez, K | 1 |
| Sorkin, M | 1 |
| Vaishampayan, A | 1 |
| Goverman, J | 1 |
| Sheridan, RL | 1 |
| Friedstat, J | 1 |
| Schulz, JT | 1 |
| Schneider, JC | 1 |
| Levi, B | 1 |
| Ryan, CM | 1 |
| Zavala, S | 1 |
| Gayed, RM | 1 |
| Foster, CJ | 1 |
| Jones, KM | 1 |
| Oltrogge Pape, K | 1 |
| Hill, DM | 1 |
| Reger, M | 1 |
| Cochran, A | 1 |
| Thuet, W | 1 |
| Holt, B | 1 |
| Faraklas, I | 1 |
| Smout, RJ | 1 |
| Horn, SD | 1 |
| Breederveld, RS | 2 |
| Tuinebreijer, WE | 2 |
| Real, DS | 1 |
| Reis, RP | 1 |
| Piccolo, MS | 1 |
| Okamoto, RH | 1 |
| Gragnani, A | 1 |
| Ferreira, LM | 1 |
| Diaz, EC | 1 |
| Børsheim, E | 1 |
| Li, H | 1 |
| Guo, Y | 1 |
| Yang, Z | 1 |
| Roy, M | 1 |
| Guo, Q | 1 |
| Reeves, PT | 1 |
| Tanksley, JD | 1 |
| Klein, GL | 4 |
| Clayton, RP | 1 |
| Crites, NN | 1 |
| Hays, JP | 1 |
| Andersen, C | 1 |
| Lee, JO | 2 |
| Meyer, W | 1 |
| Voigt, CD | 1 |
| Wurzer, P | 1 |
| Guillory, A | 1 |
| Kline, A | 1 |
| Andersen, CR | 1 |
| Tompkins, RG | 1 |
| Miller, JT | 2 |
| Btaiche, IF | 2 |
| Gauglitz, GG | 1 |
| Williams, FN | 1 |
| Tuvdendorj, D | 1 |
| Chinkes, DL | 6 |
| Zhang, XJ | 1 |
| Aarsland, A | 1 |
| Ferrando, A | 1 |
| Kulp, GA | 1 |
| Wolfe, RR | 3 |
| Porro, LJ | 1 |
| Rodriguez, NA | 1 |
| Rojas, Y | 1 |
| Radhakrishnan, RS | 1 |
| Barrow, RE | 2 |
| Dasu, MR | 2 |
| Ferrando, AA | 3 |
| Spies, M | 1 |
| Thomas, SJ | 2 |
| Perez-Polo, JR | 1 |
| Wolf, SE | 3 |
| Demling, RH | 5 |
| DeSanti, L | 3 |
| Murphy, KD | 2 |
| Gottschlich, MM | 1 |
| Mayes, T | 1 |
| Khoury, J | 1 |
| Warden, GD | 1 |
| Przkora, R | 2 |
| Sanford, AP | 1 |
| Lee, J | 1 |
| Pereira, CT | 1 |
| Ipaktchi, K | 1 |
| Arbabi, S | 1 |
| Kulp, G | 1 |
| Orgill, DP | 1 |
| Hart, DW | 1 |
| Ramzy, PI | 1 |
| Beauford, RB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of a Pulmonary Rehabilitation on Lung Function and Exercise Capacity in Patients With Burn: a Prospective Randomized Single Blind Study[NCT04125108] | 120 participants (Actual) | Interventional | 2019-10-10 | Completed | |||
| Efficacy of Testosterone Gel to Restore Normal Serum Values of Testosterone During the Acute Phase of Critical Illness in Adult ICU Patients[NCT03678233] | Phase 2 | 30 participants (Anticipated) | Interventional | 2019-06-27 | Recruiting | ||
| Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors[NCT00239668] | 3,000 participants (Anticipated) | Observational | 2000-03-31 | Completed | |||
| Assessment of the Treatment of the Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation[NCT00675714] | Phase 2/Phase 3 | 1,126 participants (Actual) | Interventional | 2004-01-31 | Terminated (stopped due to At the request of the study site, this study has been closed and access to study-related data is unavailable. We are unable to submit the results-data.) | ||
| Ability of Oral Steroid (Oxandrolone) to Halt Fatty Infiltration and Aid Rotator Cuff Healing: A Double-Blind, Randomized Clinical Trial[NCT03091075] | 116 participants (Anticipated) | Interventional | 2018-09-23 | Active, not recruiting | |||
| Vitamin D Deficiency in Acutely Injured Pediatric Burn Patients: Incidence, Etiology, Metabolic Sequelae and Prevention[NCT00536276] | Phase 1 | 50 participants (Actual) | Interventional | 2003-03-31 | Completed | ||
| Randomized, Controlled, Multicenter Study of the Effect of In-Patient Exercise Training on Length of Hospitalization, Mental Health, and Physical Performance in Burned Patients[NCT02739464] | 77 participants (Actual) | Interventional | 2014-09-15 | Completed | |||
| Xbox Kinect™ to Promote Physical Fitness and Lean Mass in Severely Burned Children: A Randomized Controlled Trial[NCT04350034] | 40 participants (Actual) | Interventional | 2016-06-15 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
15 reviews available for oxandrolone and Burns
| Article | Year |
|---|---|
Metabolic and Nutritional Support.
Topics: Anabolic Agents; Burns; Humans; Insulin; Nutritional Support; Oxandrolone | 2023 |
Oxandrolone in the Treatment of Burn Injuries: A Systematic Review and Meta-analysis.
Topics: Adolescent; Adult; Aged; Anabolic Agents; Burns; Child; Child, Preschool; Humans; Incidence; Length | 2020 |
Anabolic and anticatabolic agents used in burn care: What is known and what is yet to be learned.
Topics: Anabolic Agents; Burns; Clonidine; Growth Hormone-Releasing Hormone; Hormones; Human Growth Hormone; | 2020 |
Burn-induced hypermetabolism and skeletal muscle dysfunction.
Topics: Burns; Cachexia; Epigenesis, Genetic; Exercise; Human Growth Hormone; Humans; Insulin; Metformin; Mu | 2021 |
Recombinant human growth hormone for treating burns and donor sites.
Topics: Adolescent; Adult; Aged; Anabolic Agents; Body Surface Area; Burns; Child; Child, Preschool; Human G | 2014 |
Oxandrolone use in adult burn patients. Systematic review and meta-analysis.
Topics: Adult; Body Mass Index; Burns; Humans; Length of Stay; Nitrogen; Oxandrolone; Randomized Controlled | 2014 |
Effects of pharmacological interventions on muscle protein synthesis and breakdown in recovery from burns.
Topics: Adrenergic beta-Antagonists; Anabolic Agents; Androgens; Body Surface Area; Burns; Human Growth Horm | 2015 |
The efficacy and safety of oxandrolone treatment for patients with severe burns: A systematic review and meta-analysis.
Topics: Anabolic Agents; Body Composition; Body Weight; Burns; Chemical and Drug Induced Liver Injury; Human | 2016 |
Oxandrolone in pediatric patients with severe thermal burn injury.
Topics: Anabolic Agents; Burns; Child; Humans; Metabolic Diseases; Oxandrolone | 2008 |
Oxandrolone treatment in adults with severe thermal injury.
Topics: Adult; Anabolic Agents; Body Weight; Burns; Clinical Trials as Topic; Humans; Nutritional Support; O | 2009 |
Burns: where are we standing with propranolol, oxandrolone, recombinant human growth hormone, and the new incretin analogs?
Topics: Anabolic Agents; Blood Glucose; Burns; Growth Hormone; Humans; Insulin; Insulin Resistance; Insulin- | 2011 |
Burns: an update on current pharmacotherapy.
Topics: Adrenergic beta-Antagonists; Anabolic Agents; Animals; Burns; Growth Hormone; Humans; Hypoglycemic A | 2012 |
Recombinant human growth hormone for treating burns and donor sites.
Topics: Adolescent; Adult; Aged; Anabolic Agents; Body Surface Area; Burns; Child; Child, Preschool; Human G | 2012 |
The pharmacologic modulation of the hypermetabolic response to burns.
Topics: Adrenergic beta-Antagonists; Anabolic Agents; Burns; Catecholamines; Humans; Hypoglycemic Agents; In | 2005 |
Advances in burn critical care.
Topics: Adrenergic beta-Antagonists; Anabolic Agents; Burns; Critical Care; Humans; Immunotherapy; Nutrition | 2006 |
18 trials available for oxandrolone and Burns
| Article | Year |
|---|---|
Propranolol and Oxandrolone Therapy Accelerated Muscle Recovery in Burned Children.
Topics: Adolescent; Basal Metabolism; Body Composition; Burns; Cardiorespiratory Fitness; Child; Exercise Th | 2018 |
Reduced Postburn Hypertrophic Scarring and Improved Physical Recovery With Yearlong Administration of Oxandrolone and Propranolol.
Topics: Adolescent; Anabolic Agents; Biomarkers; Biopsy; Burns; Child; Cicatrix, Hypertrophic; Double-Blind | 2018 |
FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL.
Topics: Administration, Oral; Bone Density; Burns; Child; Female; Follow-Up Studies; Humans; Male; Muscle St | 2016 |
Reversal of Growth Arrest With the Combined Administration of Oxandrolone and Propranolol in Severely Burned Children.
Topics: Adolescent; Burns; Child; Child, Preschool; Drug Therapy, Combination; Female; Growth; Growth Disord | 2016 |
Reversal of Growth Arrest With the Combined Administration of Oxandrolone and Propranolol in Severely Burned Children.
Topics: Adolescent; Burns; Child; Child, Preschool; Drug Therapy, Combination; Female; Growth; Growth Disord | 2016 |
Reversal of Growth Arrest With the Combined Administration of Oxandrolone and Propranolol in Severely Burned Children.
Topics: Adolescent; Burns; Child; Child, Preschool; Drug Therapy, Combination; Female; Growth; Growth Disord | 2016 |
Reversal of Growth Arrest With the Combined Administration of Oxandrolone and Propranolol in Severely Burned Children.
Topics: Adolescent; Burns; Child; Child, Preschool; Drug Therapy, Combination; Female; Growth; Growth Disord | 2016 |
Long-term oxandrolone treatment increases muscle protein net deposition via improving amino acid utilization in pediatric patients 6 months after burn injury.
Topics: Amino Acids; Anabolic Agents; Burns; Child; Follow-Up Studies; Humans; Leg; Longitudinal Studies; Mu | 2011 |
Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy.
Topics: Adolescent; Anabolic Agents; Biomarkers; Body Size; Bone Density; Burns; Calorimetry, Indirect; Chil | 2012 |
Gene expression patterns in skeletal muscle of thermally injured children treated with oxandrolone.
Topics: Adolescent; Anabolic Agents; Blotting, Western; Burns; Child; Child, Preschool; Gene Expression Prof | 2003 |
Improved net protein balance, lean mass, and gene expression changes with oxandrolone treatment in the severely burned.
Topics: Amino Acids; Anabolic Agents; Body Composition; Burns; Child; Food Additives; Food, Formulated; Gene | 2003 |
Oxandrolone induced lean mass gain during recovery from severe burns is maintained after discontinuation of the anabolic steroid.
Topics: Adult; Anabolic Agents; Body Composition; Burns; Female; Humans; Middle Aged; Nutritional Physiologi | 2003 |
The long-term effect of oxandrolone on hepatic acute phase proteins in severely burned children.
Topics: Acute-Phase Proteins; Adolescent; Anabolic Agents; Burn Units; Burns; Child; Child, Preschool; Femal | 2004 |
Effects of long-term oxandrolone administration in severely burned children.
Topics: Adolescent; Androgens; Bone Density; Burns; Child; Child, Preschool; Double-Blind Method; Female; Hu | 2004 |
Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment.
Topics: Adolescent; Anabolic Agents; Body Mass Index; Body Size; Bone Density; Burns; Child; Child, Preschoo | 2005 |
The effects of oxandrolone and exercise on muscle mass and function in children with severe burns.
Topics: Adolescent; Anabolic Agents; Body Mass Index; Body Weight; Burns; Child; Exercise Test; Exercise The | 2007 |
The effects of oxandrolone and exercise on muscle mass and function in children with severe burns.
Topics: Adolescent; Anabolic Agents; Body Mass Index; Body Weight; Burns; Child; Exercise Test; Exercise The | 2007 |
The effects of oxandrolone and exercise on muscle mass and function in children with severe burns.
Topics: Adolescent; Anabolic Agents; Body Mass Index; Body Weight; Burns; Child; Exercise Test; Exercise The | 2007 |
The effects of oxandrolone and exercise on muscle mass and function in children with severe burns.
Topics: Adolescent; Anabolic Agents; Body Mass Index; Body Weight; Burns; Child; Exercise Test; Exercise The | 2007 |
The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn.
Topics: Anabolic Agents; Analysis of Variance; Body Composition; Body Mass Index; Burns; Calorimetry, Indire | 2007 |
The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn.
Topics: Anabolic Agents; Analysis of Variance; Body Composition; Body Mass Index; Burns; Calorimetry, Indire | 2007 |
The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn.
Topics: Anabolic Agents; Analysis of Variance; Body Composition; Body Mass Index; Burns; Calorimetry, Indire | 2007 |
The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn.
Topics: Anabolic Agents; Analysis of Variance; Body Composition; Body Mass Index; Burns; Calorimetry, Indire | 2007 |
Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns.
Topics: Adult; Anabolic Agents; Burns; Dietary Proteins; Energy Intake; Female; Humans; Male; Oxandrolone; P | 1997 |
Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury.
Topics: Adult; Aged; Anabolic Agents; Analysis of Variance; Burns; Female; Follow-Up Studies; Human Growth H | 1999 |
The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury.
Topics: Adult; Aged; Anabolic Agents; Burns; Double-Blind Method; Energy Intake; Humans; Length of Stay; Liv | 2000 |
The rate of restoration of body weight after burn injury, using the anabolic agent oxandrolone, is not age dependent.
Topics: Adolescent; Adult; Age Factors; Anabolic Agents; Burns; Humans; Male; Middle Aged; Oxandrolone; Weig | 2001 |
10 other studies available for oxandrolone and Burns
| Article | Year |
|---|---|
Vitamin A-Induced Hypercalcemia in Burn Patients: A Case Study.
Topics: Adolescent; Burns; Calcium; Humans; Hypercalcemia; Male; Oxandrolone; Vitamin A; Vitamin D; Vitamins | 2022 |
Assessment of the impact of oxandrolone on outcomes in burn injured patients.
Topics: Adult; Anabolic Agents; Body Weight; Burns; Burns, Inhalation; Female; Humans; Length of Stay; Longi | 2019 |
Incidence of oxandrolone induced hepatic transaminitis in patients with burn injury.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Anabolic Agents; Aspartate Aminotransferases; Bil | 2019 |
Topical Oxandrolone Reduces Ear Hypertrophic Scar Formation in Rabbits.
Topics: Administration, Topical; Anabolic Agents; Animals; Biocompatible Materials; Burns; Cicatrix, Hypertr | 2019 |
Oxandrolone protects against the development of multiorgan failure, modulates the systemic inflammatory response and promotes wound healing during burn injury.
Topics: Amylases; Anabolic Agents; Animals; Burns; Cytokines; Heart; Inflammation; Kidney; Liver; Lung; Malo | 2019 |
Investigation into Possible Association of Oxandrolone and Heterotopic Ossification Following Burn Injury.
Topics: Adult; Anabolic Agents; Animals; Burns; Female; Humans; Male; Mice; Models, Animal; Ossification, He | 2019 |
Risk Factors Associated with the Development of Transaminitis in Oxandrolone-Treated Adult Burn Patients.
Topics: Adult; Age Factors; Anabolic Agents; Burns; Chemical and Drug Induced Liver Injury; Female; Humans; | 2019 |
The impact of oxandrolone on length of stay following major burn injury: a clinical practice evaluation.
Topics: Adult; Aged; Anabolic Agents; Burns; Case-Control Studies; Female; Humans; Length of Stay; Male; Mid | 2013 |
Hypovitaminosis D in acutely injured pediatric burn patients.
Topics: Adolescent; Anabolic Agents; Burns; Child; Child, Preschool; Ergocalciferols; Growth Hormone; Humans | 2004 |
Anabolic effects of oxandrolone after severe burn.
Topics: Anabolic Agents; Burns; Case-Control Studies; Child; Cohort Studies; Energy Metabolism; Female; Huma | 2001 |